HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy.

AbstractAIMS:
Nuclear factor erythroid-2-related factor 2 (Nrf2) appears to be a negative regulator of maladaptive cardiac remodelling and dysfunction; however, a potential of the Nrf2-mediated cardiac protection in diverse pathological settings remains to be determined. This study was aimed to explore the role of Nrf2 in angiotensin II (Ang II)-induced cardiac hypertrophy.
METHODS AND RESULTS:
Littermate wild-type (WT) and Nrf2 knockout (Nrf2(-/-)) mice were administered Ang II via osmotic mini-pumps for 2 weeks to induce cardiac hypertrophy. Elevation of blood pressure by the continuous Ang II infusion was comparable between WT and Nrf2(-/-) mice. Relative to WT mice, however, Nrf2(-/-) mice exhibited exaggerated myocardial oxidative stress with an impaired induction of a group of antioxidant genes and increased cardiac hypertrophy in response to the sustained Ang II stimulation. In cultured cardiomyocytes, adenoviral overexpression of Nrf2 shRNA enhanced Ang II-induced reactive oxygen species (ROS) production and protein synthesis, whereas adenoviral overexpression of Nrf2 exerted opposite effects. Moreover, Nrf2 deficiency exacerbated Ang II-induced down-regulation of p27(kip1) expression in the heart via a mechanism of post-transcriptional regulation. In contrast, adenoviral overexpression of Nrf2 increased p27(kip1) protein but not mRNA expression and reversed Ang II-induced down-regulation of p27(kip1) protein expression in cultured cardiomyocytes by suppressing ROS formation. Finally, the enhancement of Ang II-induced hypertrophic growth due to the Nrf2 deficiency was negated by overexpressing p27(kip1) in cultured cardiomyocytes.
CONCLUSION:
The Nrf2-p27(kip1) pathway serves as a novel negative feedback mechanism in Ang II-induced pathogenesis of cardiac hypertrophy, independent of changes in blood pressure.
AuthorsJinqing Li, Cheng Zhang, Yifan Xing, Joseph S Janicki, Masayuki Yamamoto, Xing Li Wang, Dong-Qi Tang, Taixing Cui
JournalCardiovascular research (Cardiovasc Res) Vol. 90 Issue 2 Pg. 315-24 (May 01 2011) ISSN: 1755-3245 [Electronic] England
PMID21245055 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cdkn1b protein, mouse
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Phenols
  • Plant Extracts
  • RNA, Small Interfering
  • Vasoconstrictor Agents
  • antioxidant biofactor AOB
  • Angiotensin II
  • Cyclin-Dependent Kinase Inhibitor p27
Topics
  • Angiotensin II (pharmacology)
  • Animals
  • Blood Pressure (drug effects, physiology)
  • Cardiomegaly (chemically induced, metabolism, physiopathology)
  • Cells, Cultured
  • Cyclin-Dependent Kinase Inhibitor p27 (genetics, metabolism)
  • Feedback, Physiological (physiology)
  • Male
  • Mice
  • Myocytes, Cardiac (cytology, metabolism)
  • NF-E2-Related Factor 2 (genetics, metabolism)
  • Oxidative Stress (physiology)
  • Phenols (metabolism)
  • Plant Extracts (metabolism)
  • RNA Processing, Post-Transcriptional (physiology)
  • RNA, Small Interfering
  • Rats
  • Up-Regulation (physiology)
  • Vasoconstrictor Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: